CARY – THREAD, a growing provider of services for clinical trials, is continuing its expansion with a second acquisition in recent months.
THREAD on Wednesday disclosed buying inVibe, which provides voice-powered technology solutions for life science and healthcare providers. Financial terms weren’t disclosed, but THREAD says all of inVibe’s employees will become part of its workforce.
InVibe has offices in California and Pennsylvania.
“inVibe is a pioneer in the field of voice technology, having developed the first and only research platform designed exclusively for the healthcare industry,” the company notes at its website. “Awarded for its innovations by its peers, the inVibe team was recognized in 2019, 2020, and 2021 as one of America’s 5000 Fastest Growing Companies by the prestigious Inc. Magazine. They most recently were awarded a spot on the Deloitte Fast 500 list.”
The Cary firm said it would add voice services to its participant as well as clinical trial research and design capabilities.
In November, THREAD acquired Modus Outcomes.
“inVibe adds capabilities to the THREAD platform that allow us to integrate the power of voice into clinical research. This will help us as we seek to create the best possible trial experiences for participants and all other study stakeholders. The ability to analyze and integrate data from listening technology is currently missing from other top players in the industry. We are moving the needle when it comes to delivering adaptive, patient-centered research experiences,” said John Reites, CEO of THREAD.
